US Equities Analysis

A — Agilent Technologies

A A Price Chart

Agilent Technologies (A) is a life sciences tools & services company in the Health Care sector. Listed on the NASDAQ, Agilent Technologies is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $131.62.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$131.62
Latest Date2026-06-10
Expected Return (Annualized)3.42%
Risk / Std Dev (Annualized)29.97%
Sharpe Ratio (rf=4.5%)-0.04

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of 3.42% with an annualized volatility of 29.97%. The Sharpe ratio of -0.04 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap37.17B
Enterprise Value38.91B
Trailing P/E27.19
Forward P/E19.93
Price to Book5.22
Price to Sales5.14
EV/Revenue5.38
EV/EBITDA19.31

| Profitability | | | Profit Margin | 19.55% | | Operating Margin | 23.71% | | ROE | 21.33% | | ROA | 8.61% |

| Growth | | | Revenue Growth | 10.0% | | Earnings Growth | 60.0% |

| Dividend | | | Dividend Yield | 77.0% | | Payout Ratio | 20.2% | | 5Y Avg Yield | 68.0% |

| Financial Health | | | Total Revenue | 7.23B | | Total Debt | 3.54B | | Total Cash | 1.81B | | Free Cash Flow | 0.93B | | Operating Cash Flow | 1.45B |

| Price & Technical | | | 52W High | $160.27$ | | 52W Low | $108.35$ | | 50-Day Avg | $119.15$ | | 200-Day Avg | $130.2$ | | Beta | 1.26 | | Shares Outstanding | 0.28B | | Float Shares | 0.28B | | Insider Holdings | 0.19% | | Institutional Holdings | 94.03% | | Short Ratio | 2.02 | | Short % of Float | 2.1% |

| Analyst Targets | | | Target High | $185.0$ | | Target Low | $144.0$ | | Target Mean | $161.0$ | | Target Median | $159.5$ | | # of Analysts | 16 | | Recommendation | strong_buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity a health-care life-sciences-tools--services nasdaq